格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-057536 Act: 34 Size: 57 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-057148 Act: 34 Size: 36 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-052817 Act: 34 Size: 41 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-052581 Act: 34 Size: 255 KB 网页链接
$Alterity医疗(ATHE)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-22-052529 Act: 34 Size: 16 MB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-052518 Act: 34 Size: 3 MB 网页链接
$Alterity医疗(ATHE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-095210 Act: 34 Size: 47 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-050907 Act: 34 Size: 35 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-22-050622 Act: 34 Size: 32 KB 网页链接
$Alterity医疗(ATHE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-084800 Act: 34 Size: 46 KB 网页链接